Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H13N3O3 |
| Molecular Weight | 259.2606 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1CC(=O)NN=C1C2=CC=C3NC(=O)COC3=C2
InChI
InChIKey=XZPGINPFWXLYNW-UHFFFAOYSA-N
InChI=1S/C13H13N3O3/c1-7-4-11(17)15-16-13(7)8-2-3-9-10(5-8)19-6-12(18)14-9/h2-3,5,7H,4,6H2,1H3,(H,14,18)(H,15,17)
| Molecular Formula | C13H13N3O3 |
| Molecular Weight | 259.2606 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2153210
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2153210
Bemoradan (RWJ-22867), a potent positive inotropic agent, inhibits cardiac phosphodiesterase fraction III. This compound was developed for the management of congestive heart failure. However, the information about the nowadays study of bemoradan is not available.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Evaluation of the excretion, and metabolism of the cardiotonic agent bemoradan in male rats and female beagle dogs. | 2002-01-26 |
|
| Pharmacokinetics and bioavailability of bemoradan, a long-acting inodilator in healthy males. | 1994-02 |
|
| Simultaneous monitoring of bemoradan pharmacokinetics and hemodynamics in mongrel dogs. | 1992-10 |
|
| Heteroatom analogues of bemoradan: chemistry and cardiotonic activity of 1,4-benzothiazinylpyridazinones. | 1992-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8004360
bemoradan HCL salt in capsules. 0.5, 1, 1.5 and 2 mg of bemoradan
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:14:31 GMT 2025
by
admin
on
Mon Mar 31 18:14:31 GMT 2025
|
| Record UNII |
G2S2V1ETBQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C744
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5362399
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
AA-49
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
SUB05695MIG
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
C062457
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL46765
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
100000086569
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
6422
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
112018-01-6
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
C76314
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY | |||
|
G2S2V1ETBQ
Created by
admin on Mon Mar 31 18:14:31 GMT 2025 , Edited by admin on Mon Mar 31 18:14:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |